INTREXON ACTOBIOTICS NV has a total of 58 patent applications. It decreased the IP activity by 60.0%. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are ACTOGENIX NV, SEED BRIAN and PROTECH PHARMA S A.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 22 | |
#2 | United States | 16 | |
#3 | Australia | 9 | |
#4 | Hong Kong | 3 | |
#5 | Hungary | 3 | |
#6 | Japan | 3 | |
#7 | Canada | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Foods | |
#6 | Fodder | |
#7 | Fermentation | |
#8 | Enzymes | |
#9 | Microorganisms | |
#10 | Special bacteria in foodstuffs |
# | Name | Total Patents |
---|---|---|
#1 | Steidler Lothar | 36 |
#2 | Vandenbroucke Klaas | 25 |
#3 | Van Huynegem Karolien | 23 |
#4 | Rottiers Pieter | 19 |
#5 | Snoeck Veerle | 13 |
#6 | Neirynck Sabine | 5 |
#7 | Dhaese Patrick | 3 |
#8 | Klaas Vandenbroucke | 3 |
#9 | Corveleyn Sam | 3 |
#10 | Sabine Neirynck | 2 |
Publication | Filing date | Title |
---|---|---|
EP3382006A1 | Modified gram positive bacteria and uses thereof | |
EP2758512A1 | Modified gram positive bacteria and uses thereof | |
EP2483409A1 | LACTOBACILLUS glyceraldehyde-3-phosphate dehydrogenase PROMOTERS AND USES THEREOF | |
EP3181682A1 | Reduced colonization of microbes at the mucosa | |
EP2115146A2 | Lactococcus promoters and uses thereof | |
EP1957100A1 | Induction of mucosal tolerance to antigens | |
CA2925307A1 | Novel treatment of chronic enterocolitis | |
AU2003250250A1 | Methods and means to promote gut absorption |